Evaluation of intestinal microbiota, short-chain fatty acids, and immunoglobulin a in diversion colitis

It is reported that an increase in aerobic bacteria, a lack of short-chain fatty acids (SCFAs), and immune disorders in the diverted colon are major causes of diversion colitis. However, the precise pathogenesis of this condition remains unclear. The aim of the present study was to examine the micro...

Full description

Bibliographic Details
Main Authors: Kentaro Tominaga, Atsunori Tsuchiya, Takeshi Mizusawa, Asami Matsumoto, Ayaka Minemura, Kentaro Oka, Motomichi Takahashi, Tomoaki Yosida, Yuzo Kawata, Kazuya Takahashi, Hiroki Sato, Satoshi Ikarashi, Kazunao Hayashi, Ken-ichi Mizuno, Yosuke Tajima, Masato Nakano, Yoshifumi Shimada, Hitoshi Kameyama, Junji Yokoyama, Toshifumi Wakai, Shuji Terai
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:Biochemistry and Biophysics Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405580820302028
id doaj-4d395b1d532e4444b5ab20836e1c1673
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Kentaro Tominaga
Atsunori Tsuchiya
Takeshi Mizusawa
Asami Matsumoto
Ayaka Minemura
Kentaro Oka
Motomichi Takahashi
Tomoaki Yosida
Yuzo Kawata
Kazuya Takahashi
Hiroki Sato
Satoshi Ikarashi
Kazunao Hayashi
Ken-ichi Mizuno
Yosuke Tajima
Masato Nakano
Yoshifumi Shimada
Hitoshi Kameyama
Junji Yokoyama
Toshifumi Wakai
Shuji Terai
spellingShingle Kentaro Tominaga
Atsunori Tsuchiya
Takeshi Mizusawa
Asami Matsumoto
Ayaka Minemura
Kentaro Oka
Motomichi Takahashi
Tomoaki Yosida
Yuzo Kawata
Kazuya Takahashi
Hiroki Sato
Satoshi Ikarashi
Kazunao Hayashi
Ken-ichi Mizuno
Yosuke Tajima
Masato Nakano
Yoshifumi Shimada
Hitoshi Kameyama
Junji Yokoyama
Toshifumi Wakai
Shuji Terai
Evaluation of intestinal microbiota, short-chain fatty acids, and immunoglobulin a in diversion colitis
Biochemistry and Biophysics Reports
Diversion colitis
Microbiota
Short-chain fatty acids
Immunoglobulin A
author_facet Kentaro Tominaga
Atsunori Tsuchiya
Takeshi Mizusawa
Asami Matsumoto
Ayaka Minemura
Kentaro Oka
Motomichi Takahashi
Tomoaki Yosida
Yuzo Kawata
Kazuya Takahashi
Hiroki Sato
Satoshi Ikarashi
Kazunao Hayashi
Ken-ichi Mizuno
Yosuke Tajima
Masato Nakano
Yoshifumi Shimada
Hitoshi Kameyama
Junji Yokoyama
Toshifumi Wakai
Shuji Terai
author_sort Kentaro Tominaga
title Evaluation of intestinal microbiota, short-chain fatty acids, and immunoglobulin a in diversion colitis
title_short Evaluation of intestinal microbiota, short-chain fatty acids, and immunoglobulin a in diversion colitis
title_full Evaluation of intestinal microbiota, short-chain fatty acids, and immunoglobulin a in diversion colitis
title_fullStr Evaluation of intestinal microbiota, short-chain fatty acids, and immunoglobulin a in diversion colitis
title_full_unstemmed Evaluation of intestinal microbiota, short-chain fatty acids, and immunoglobulin a in diversion colitis
title_sort evaluation of intestinal microbiota, short-chain fatty acids, and immunoglobulin a in diversion colitis
publisher Elsevier
series Biochemistry and Biophysics Reports
issn 2405-5808
publishDate 2021-03-01
description It is reported that an increase in aerobic bacteria, a lack of short-chain fatty acids (SCFAs), and immune disorders in the diverted colon are major causes of diversion colitis. However, the precise pathogenesis of this condition remains unclear. The aim of the present study was to examine the microbiota, intestinal SCFAs, and immunoglobulin A (IgA) in the diverted colon. Eight patients underwent operative procedures for colostomies. We assessed the diverted colon using endoscopy and obtained intestinal samples from the diverted colon and oral colon in these patients. We analyzed the microbiota and SCFAs of the intestinal samples. The bacterial communities were investigated using a 16S rRNA gene sequencing method. The microbiota demonstrated a change in the proportion of some species, especially Lactobacillus, which significantly decreased in the diverted colon at the genus level. We also showed that intestinal SCFA values were significantly decreased in the diverted colon. Furthermore, intestinal IgA levels were significantly increased in the diverted colon. This study was the first to show that intestinal SCFAs were significantly decreased and intestinal IgA was significantly increased in the diverted colon. Our data suggest that SCFAs affect the microbiota and may play an immunological role in diversion colitis.
topic Diversion colitis
Microbiota
Short-chain fatty acids
Immunoglobulin A
url http://www.sciencedirect.com/science/article/pii/S2405580820302028
work_keys_str_mv AT kentarotominaga evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT atsunoritsuchiya evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT takeshimizusawa evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT asamimatsumoto evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT ayakaminemura evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT kentarooka evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT motomichitakahashi evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT tomoakiyosida evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT yuzokawata evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT kazuyatakahashi evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT hirokisato evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT satoshiikarashi evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT kazunaohayashi evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT kenichimizuno evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT yosuketajima evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT masatonakano evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT yoshifumishimada evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT hitoshikameyama evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT junjiyokoyama evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT toshifumiwakai evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
AT shujiterai evaluationofintestinalmicrobiotashortchainfattyacidsandimmunoglobulinaindiversioncolitis
_version_ 1724274594932588544
spelling doaj-4d395b1d532e4444b5ab20836e1c16732021-02-11T04:22:19ZengElsevierBiochemistry and Biophysics Reports2405-58082021-03-0125100892Evaluation of intestinal microbiota, short-chain fatty acids, and immunoglobulin a in diversion colitisKentaro Tominaga0Atsunori Tsuchiya1Takeshi Mizusawa2Asami Matsumoto3Ayaka Minemura4Kentaro Oka5Motomichi Takahashi6Tomoaki Yosida7Yuzo Kawata8Kazuya Takahashi9Hiroki Sato10Satoshi Ikarashi11Kazunao Hayashi12Ken-ichi Mizuno13Yosuke Tajima14Masato Nakano15Yoshifumi Shimada16Hitoshi Kameyama17Junji Yokoyama18Toshifumi Wakai19Shuji Terai20Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan; Corresponding author. Division of Gastroenterology and Hepatology Graduate School of Medical and Dental Sciences Niigata University, 1–757 Asahimachi–dori Chuo–ku, Niigata, 9518510, Japan.Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanResearch Department, R&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama, JapanResearch Department, R&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama, JapanResearch Department, R&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama, JapanResearch Department, R&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama, JapanDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanDivision of Digestive and General Surgery, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanDivision of Digestive and General Surgery, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanDivision of Digestive and General Surgery, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanDivision of Digestive and General Surgery, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanDivision of Digestive and General Surgery, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan; Corresponding author. Division of Gastroenterology and Hepatology Graduate School of Medical and Dental Sciences Niigata University, 1–757 Asahimachi–dori Chuo–ku, Niigata, 9518510, Japan.It is reported that an increase in aerobic bacteria, a lack of short-chain fatty acids (SCFAs), and immune disorders in the diverted colon are major causes of diversion colitis. However, the precise pathogenesis of this condition remains unclear. The aim of the present study was to examine the microbiota, intestinal SCFAs, and immunoglobulin A (IgA) in the diverted colon. Eight patients underwent operative procedures for colostomies. We assessed the diverted colon using endoscopy and obtained intestinal samples from the diverted colon and oral colon in these patients. We analyzed the microbiota and SCFAs of the intestinal samples. The bacterial communities were investigated using a 16S rRNA gene sequencing method. The microbiota demonstrated a change in the proportion of some species, especially Lactobacillus, which significantly decreased in the diverted colon at the genus level. We also showed that intestinal SCFA values were significantly decreased in the diverted colon. Furthermore, intestinal IgA levels were significantly increased in the diverted colon. This study was the first to show that intestinal SCFAs were significantly decreased and intestinal IgA was significantly increased in the diverted colon. Our data suggest that SCFAs affect the microbiota and may play an immunological role in diversion colitis.http://www.sciencedirect.com/science/article/pii/S2405580820302028Diversion colitisMicrobiotaShort-chain fatty acidsImmunoglobulin A